MINNESOTA

Bongards Creameries is planning to expand its dairy processing plant in Perham. The project scope includes construction of building space for expanded milk intake bays, whey warehousing, and wastewater treatment; as well as purchase and installation of stainless steel tanks and piping, spray drying, filling, whey and cheese packaging, and wastewater treatment equipment. The project will increase milk processing capacity by 30% to 5.5 million lb of milk per day. Hammers Construction Inc. has been selected as the general contractor. Construction is expected to begin in July 2023 and be completed in June 2025. The estimated EPC cost is $125 million. Bongards Creameries, 110 Third Ave. NE, Perham, 56673. IR#MN230603.

NEW HAMPSHIRE

Lonza Biologics Inc., in partnership with Vertex Pharmaceuticals, is planning to construct a cell therapies production facility at Lonza’s campus in Portsmouth. The project scope includes construction of a 130,000-sq-ft building with cleanroom space; and purchase and installation of stainless steel piping, freezers, fume hoods, bioreactors, and wet laboratory, filtration, purification, sterile filling, testing, air handling, sterilization, labeling and packaging equipment. Construction is expected to begin in the late third or fourth quarter of 2023. The plant will be used to manufacture insulin-producing islet cell therapies for the treatment of type 1 diabetes. The estimated EPC cost is between $40 million and $45 million. Lonza Biologics Inc., 101 International Drive, Portsmouth, 03801. IR#NH230603.